ClinicalTrials.Veeva

Menu

Minimal Extracorporeal Circuits (MECC) in Cardiac Surgery Procedures

J

Johann Wolfgang Goethe University Hospital

Status

Completed

Conditions

Postoperative Bloodloss

Treatments

Device: MECC
Device: Super MOPS
Device: MOPS

Study type

Interventional

Funder types

Other

Identifiers

NCT01306903
Mini-ECC001AHK

Details and patient eligibility

About

The standard heart-lung machine is a major trigger of systemic inflammatory reactions, hemodilution, coagulopathy or organ failure. The strict reduction of blood-artificial surface and blood-air contact might represent meaningful improvements of the extracorporeal technology with respect to organ preservation.

The aim of this study is the evaluation of potential differences between a minimal extracorporeal circuit (MECC) and a conventional cardiopulmonary bypass (MOPS) system.

Enrollment

68 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • extracorporeal circulation
  • age > 18 years old

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

68 participants in 3 patient groups, including a placebo group

MECC
Experimental group
Description:
Minimal extracorporeal circuit
Treatment:
Device: MECC
MOPS
Placebo Comparator group
Treatment:
Device: MOPS
Super MOPS
Placebo Comparator group
Treatment:
Device: Super MOPS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems